NCT06309368

Brief Summary

The goal of this clinical trial is to compare two types of closure in patients with ostomies that are ready for closure. The main questions it aims to answer are:

  1. 1.Surgical site infection rates
  2. 2.Patient quality of life
  3. 3.Time to wound healing

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for phase_4

Timeline
44mo left

Started Mar 2024

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Mar 2024Dec 2029

First Submitted

Initial submission to the registry

February 22, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 13, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

March 14, 2024

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

June 2, 2025

Status Verified

May 1, 2025

Enrollment Period

4.7 years

First QC Date

February 22, 2024

Last Update Submit

May 27, 2025

Conditions

Keywords

OstomySurgical Site InfectionPrimary ClosureSecondary Closure

Outcome Measures

Primary Outcomes (1)

  • Surgical Site Infection Rates

    Evaluate surgical site infection rates between the two treatment arms

    Evaluate surgical site for any signs of infection up to 30 days post-operatively.

Secondary Outcomes (5)

  • Acceptability of wound or scar healing by patient

    Up to one year post-operatively.

  • Amount of percepted wound care needed by patient

    Up to 4 weeks after compete wound closure.

  • Acceptability of wound and scar healing by patient

    At 4 weeks post complete wound closure and at one year post-operatively.

  • Wound healing

    Until complete wound closure (estimated up to 4-6 weeks post-operation).

  • Acceptability of wound and scar healing by patient

    Up to one year post-operatively

Study Arms (2)

Primary Closure with 0.1% Betaine/0.1% Polyhexanide Wound Irrigation

ACTIVE COMPARATOR

The ostomy wound will be irrigated with 0.1% Betaine/0.1% Polyhexanide wound irrigation, then closed completely with sutures.

Drug: Primary Ostomy Closure with 0.1% Betaine/0.1% Polyhexanide Wound Irrigation

Secondary Closure with Pursestring

ACTIVE COMPARATOR

The ostomy wound will be partially closed using the Pursestring method.

Procedure: Pursestring Closure

Interventions

An elliptical transverse incision will be made extending 1-2 cm lateral and medial to the mucocutaneous junction. The mobilization, anastomosis and fascial closure will be performed as in the pursestring closure group. The incision will then be irrigated using direct stream into the wound with 350cc of Prontosan. After one minute the wound will be suctioned dry. The subcutaneous fat will be mobilized and approximated with interrupted 2-0 Vicryl. The skin will be approximated with deep dermal 3-0 Vicryl and a running subcuticular 4-0 Monocryl suture and Dermabond will be applied.

Also known as: Prontosan
Primary Closure with 0.1% Betaine/0.1% Polyhexanide Wound Irrigation

A circular incision will be made at the mucocutaneous junction of the ileostomy. After complete mobilization of the ileal limbs off the fascia and a stapled side to side functional end to end anastomosis, the fascia including the external and posterior rectus sheath will be closed with two running #0 PDS (Polydioxanone) suture. The wound will then be irrigated with saline and partially closed in the subcuticular plane with a 2-0 Monocryl suture in a pursestring fashion and packed in the middle with plain packing.

Secondary Closure with Pursestring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients 18 years or older with an diverting loop ileostomy reversal indication will be enrolled
  • Signed consent

You may not qualify if:

  • Under 18 years old, unable to provide consent, has a parastomal hernia requiring mesh repair, or has an end ileostomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center

Las Vegas, Nevada, 89102, United States

RECRUITING

Related Publications (12)

  • van de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP. Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plast Reconstr Surg. 2005 Aug;116(2):514-22. doi: 10.1097/01.prs.0000172982.43599.d6.

    PMID: 16079683BACKGROUND
  • Cooper DM, Bojke C, Ghosh P. Cost-Effectiveness of PHMB & betaine wound bed preparation compared with standard care in venous leg ulcers: A cost-utility analysis in the United Kingdom. J Tissue Viability. 2023 May;32(2):262-269. doi: 10.1016/j.jtv.2023.03.001. Epub 2023 Mar 16.

    PMID: 36990897BACKGROUND
  • Valenzuela AR, Perucho NS. [The effectiveness of a 0.1% polyhexanide gel]. Rev Enferm. 2008 Apr;31(4):7-12. Spanish.

    PMID: 18564781BACKGROUND
  • Siddiqi A, Abdo ZE, Springer BD, Chen AF. Pursuit of the ideal antiseptic irrigation solution in the management of periprosthetic joint infections. J Bone Jt Infect. 2021 May 26;6(6):189-198. doi: 10.5194/jbji-6-189-2021. eCollection 2021.

    PMID: 34109103BACKGROUND
  • Andriessen AE, Eberlein T. Assessment of a wound cleansing solution in the treatment of problem wounds. Wounds. 2008 Jun;20(6):171-5.

    PMID: 25942522BACKGROUND
  • Goztok M, Terzi MC, Egeli T, Arslan NC, Canda AE. Does Wound Irrigation with Clorhexidine Gluconate Reduce the Surgical Site Infection Rate in Closure of Temporary Loop Ileostomy? A Prospective Clinical Study. Surg Infect (Larchmt). 2018 Aug/Sep;19(6):634-639. doi: 10.1089/sur.2018.061. Epub 2018 Jul 24.

    PMID: 30040537BACKGROUND
  • Chang Z, Liu L, She C, Ren W, Chen H, Zhou C. A meta-analysis examined the effect of stoma on surgical site wound infection in colorectal cancer. Int Wound J. 2023 May;20(5):1578-1583. doi: 10.1111/iwj.14013. Epub 2022 Nov 19.

    PMID: 36401595BACKGROUND
  • Nyandoro MG, Seow YT, Stein J, Theophilus M. Single-centre experience of loop ileostomy closure: a retrospective comparison of conventional-linear closure and purse-string closure on surgical-site-infection rates. ANZ J Surg. 2023 Mar;93(3):629-635. doi: 10.1111/ans.18083. Epub 2022 Oct 5.

    PMID: 36197316BACKGROUND
  • Zhu Y, Chen J, Lin S, Xu D. Risk factor for the development of surgical site infection following ileostomy reversal: a single-center report. Updates Surg. 2022 Oct;74(5):1675-1682. doi: 10.1007/s13304-022-01335-0. Epub 2022 Aug 24.

    PMID: 36002762BACKGROUND
  • Turner MC, Migaly J. Surgical Site Infection: The Clinical and Economic Impact. Clin Colon Rectal Surg. 2019 May;32(3):157-165. doi: 10.1055/s-0038-1677002. Epub 2019 Apr 2.

    PMID: 31061644BACKGROUND
  • Wada Y, Miyoshi N, Ohue M, Noura S, Fujino S, Sugimura K, Akita H, Motoori M, Gotoh K, Takahashi H, Kobayashi S, Ohmori T, Fujiwara Y, Yano M. Comparison of surgical techniques for stoma closure: A retrospective study of purse-string skin closure versus conventional skin closure following ileostomy and colostomy reversal. Mol Clin Oncol. 2015 May;3(3):619-622. doi: 10.3892/mco.2015.505. Epub 2015 Feb 6.

    PMID: 26137277BACKGROUND
  • Yoon SI, Bae SM, Namgung H, Park DG. Clinical trial on the incidence of wound infection and patient satisfaction after stoma closure: comparison of two skin closure techniques. Ann Coloproctol. 2015 Feb;31(1):29-33. doi: 10.3393/ac.2015.31.1.29. Epub 2015 Feb 28.

    PMID: 25745624BACKGROUND

Related Links

MeSH Terms

Conditions

Surgical Wound InfectionSurgical Wound

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsWounds and Injuries

Study Officials

  • Ovunc Bardakcioglu, MD

    Kirk Kerkorian School of Medicine at UNLV

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Abigail W Cheng, MD

CONTACT

Lance Horner, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No masking. This is a non-blinded randomized controlled trial
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of the two treatment groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Colorectal Surgery

Study Record Dates

First Submitted

February 22, 2024

First Posted

March 13, 2024

Study Start

March 14, 2024

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2029

Last Updated

June 2, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations